This funding opportunity supports pilot projects aimed at identifying new druggable targets for pain within the understudied druggable proteome. It provides funding to generate preliminary data and tools to characterize understudied proteins in the context of pain and pain management. The research focuses on basic biochemical and biological work to accelerate novel medication development for opioid addiction and pain treatment.
Eligible applicants include a wide range of organizations such as tribal governments, small businesses, institutions of higher education, nonprofits, and various government entities within the United States.
